SEC Form 4 · accession 0001144204-16-135433
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Bernstein
Director
Period of report
Nov 16, 2016
Accepted (ET)
Nov 18, 2016 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $0.52 | Nov 16, 2016 | A | 250,000 | A | — | Nov 16, 2026 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors.
- F2The stock options shall vest in equal daily installments over a five-year period beginning on the date of grant.